Smartphone Ocular Imaging for Objective Fluorescein Staining Scoring

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for assessing dry eye disease and other ocular surface diseases lack standardization and objectivity, leading to variability in diagnosis and treatment, particularly in subjective CFS scoring systems that fail to capture small increments of disease severity.

Innovation Solution

A smartphone-based system with an illumination/optics device and image processing software for accurate alignment, image acquisition, and quantification of corneal fluorescein staining, using deep learning and image processing techniques to generate a standardized CFS score.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If subjective CFS scoring is used by clinicians, then the assessment can be performed with simple equipment, but the measurement precision and reliability are poor due to variability between clinicians and readings

Engineering Contradiction:
ImproveCFS scoring precisionVSAvoidscoring system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces the manual mechanical assessment process (clinician visual inspection and subjective scoring) with an automated image processing system using deep learning algorithms. The system captures corneal images with a camera and uses computational algorithms to objectively quantify fluorescein staining, eliminating inter-clinician variability while maintaining ease of use through a digital application interface.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent creates a digital copy of the corneal surface through imaging and processes this copy using image analysis algorithms. The staining pattern is replicated as pixel data that can be quantitatively analyzed, allowing precise measurement of staining area and intensity without requiring the original physical examination to be repeated.

Inventive Principle:
Principle #26Copying

2Measurement precision

If incremental changes in disease severity are to be detected, then continuous measurement scales are needed, but current discrete scoring systems cannot capture small increments of improvement or worsening

Engineering Contradiction:
Improvedisease severity detection sensitivityVSAvoidscoring efficiency
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent transforms the discrete scoring parameters into continuous quantitative measurements by calculating the exact percentage area of stained corneal surface and the intensity distribution of fluorescein uptake. This allows detection of minimal changes in disease severity as continuous values rather than forcing them into discrete score categories, providing sensitive monitoring while maintaining computational efficiency.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If standardized diagnostic criteria are implemented, then reliability of diagnosis improves, but the heterogeneity of DED and discrepancies between symptom surveys and clinical signs complicate evaluation

Engineering Contradiction:
Improvediagnosis reliabilityVSAvoidevaluation system adaptability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent segments the corneal surface into stained and non-stained regions, providing an objective quantitative measure of epithelial damage. This segmented analysis creates a standardized metric for disease severity that can be consistently applied across different patients and clinical settings, improving diagnostic reliability while the system remains adaptable to various disease presentations through the same imaging and analysis protocol.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provides a standardized, objective, and reliable CFS scoring system that reduces variability, enabling consistent monitoring and improved management of ocular surface diseases, facilitating clinical trials and reducing the burden on healthcare systems.

Implementation Method 1

CFS reveals devitalized areas of the corneal epithelium (wounded epithelium) and areas of inflammation by the use of fluorescein dye over the ocular surface

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12357176B2System and method for acquisition and quantification of images with ocular staining
Publication Date: 2025.07.15 BOSTON EYE DIAGNOSTICS INC
  • US12357176B2 patent drawing
  • US12357176B2 patent drawing
  • US12357176B2 patent drawing

AI summary

A system for determining a staining score of portions of dyeable epithelia within the ocular surface of a subject includes a portable computing device with a camera, a display, a memory, and a processor configured to execute a staining score application. An illumination/optics device with a light source and optics is configured to receive an image of the ocular surface. The illumination/optics device may be removably attached to the portable computing device. The staining score application includes an alignment module, an image acquisition module, and a staining scoring module.